substance p has been researched along with Myocardial Infarction in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Li, X; Li, Y; Wang, Q; Wang, X; Wang, Y; Xing, X; Zhang, H; Zhang, P | 1 |
| Chen, L; Guo, Z; Li, TP; Liu, CJ; Sun, T; Zhao, X | 1 |
| Ahn, Y; Hong, HS; Hong, YJ; Jeong, MH; Kim, JH; Kim, W; Lee, KH; Lim, KS; Park, DS; Sim, DS; Son, Y; Song, HC; Woo, JS | 1 |
| Cheng, XW; Hong, HS; Kim, S; Kim, W; Lee, KH; Lee, S; Son, Y; Woo, JS | 1 |
| Guo, Z; Han, SQ; Han, Y; Liu, T; Wang, LL | 1 |
| Bergmann, A; Davies, JE; Jones, DJ; Maisel, A; Narayan, H; Ng, LL; Quinn, PA; Sandhu, JK; Squire, IB; Struck, J | 1 |
| Granger, CB; Povsic, TJ | 1 |
| Wang, DH; Zhong, B | 2 |
| Guo, Z; Wang, JP; Wang, LL; Wang, XP; Wu, J; Zhou, RH | 1 |
| Guo, Z; Wang, LL; Wu, J; Zhang, RL | 1 |
| Chia, S; Flapan, AD; Ludlam, CA; Newby, DE; Webb, DJ; Wilson, R | 1 |
| Gritman, KR; Habecker, BA; Van Winkle, DM; Willison, BD | 1 |
| Ohlin, H; Roijer, A; Thilen, U; Tingberg, E | 1 |
| Barrett, NE; Emerson, M; Gibbins, JM; Hunt, SP; Jones, S; Kaiser, WJ; Lowry, PJ; Sage, T; Tucker, KL; Zimmer, A | 1 |
| Adt, M; Ciccarelli, A; de Crescenzo, G; Marinò, I; Marone, G; Patella, V | 1 |
| Didion, SP; Mayhan, WG | 1 |
| Bergdahl, A; Edvinsson, L; Hedner, T; Nilsson, T; Sun, XY; Valdemarsson, S | 1 |
| Boon, NA; Fox, KA; Labinjoh, C; Ludlam, CA; Newby, DE; Webb, DJ; Wright, RA | 1 |
2 trial(s) available for substance p and Myocardial Infarction
| Article | Year |
|---|---|
Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation.
Topics: Acetylcholine; Analysis of Variance; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Fibrinolysis; Forearm; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Regional Blood Flow; Substance P; Treatment Failure; Vasodilator Agents; Vitamins | 2005 |
Neurohumoral changes in patients with left ventricular dysfunction following acute myocardial infarction and the effect of nitrate therapy: a randomized, double-blind, placebo-controlled long-term study.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Double-Blind Method; Echocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Norepinephrine; Renin; Substance P; Ventricular Dysfunction, Left | 2006 |
17 other study(ies) available for substance p and Myocardial Infarction
| Article | Year |
|---|---|
Electroacupuncture Treats Myocardial Infarction by Influencing the Regulation of Substance P in the Neurovascular to Modulate PGI2/TXA2 Metabolic Homeostasis via PI3K/AKT Pathway: A Bioinformatics-Based Multiomics and Experimental Study.
Topics: Animals; Class I Phosphatidylinositol 3-Kinases; Computational Biology; Electroacupuncture; Homeostasis; Humans; Mice; Molecular Docking Simulation; Myeloid Differentiation Factor 88; Myocardial Infarction; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Receptors, Epoprostenol; Receptors, Thromboxane A2, Prostaglandin H2; RNA, Messenger; Substance P; TOR Serine-Threonine Kinases | 2022 |
Association of down-regulation of calcitonin gene-related peptide and substance P with increase of myocardial vulnerability in diabetic neuropathic rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Substance P | 2017 |
Cardioprotective effect of substance P in a porcine model of acute myocardial infarction.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Infusions, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion; Random Allocation; Substance P; Swine; Treatment Outcome | 2018 |
Substance-P Prevents Cardiac Ischemia-Reperfusion Injury by Modulating Stem Cell Mobilization and Causing Early Suppression of Injury-Mediated Inflammation.
Topics: Animals; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Inflammation; Interleukin-10; Lectins, C-Type; Male; Mannose Receptor; Mannose-Binding Lectins; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Substance P; Tumor Necrosis Factor-alpha | 2019 |
Esmolol activates endogenous neurokinin activity inhibiting infarction-induced arrhythmias in rats: novel mechanisms of anti-arrhythmia.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Occlusion; Drug Evaluation, Preclinical; Gene Expression; Male; Myocardial Infarction; Myocardium; Neurokinin-1 Receptor Antagonists; Norepinephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Receptors, Neurokinin-1; Substance P | 2013 |
Pro-substance p for evaluation of risk in acute myocardial infarction.
Topics: Aged; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Single-Blind Method; Substance P | 2014 |
Another biomarker for risk assessment in acute myocardial infarction?
Topics: Female; Humans; Male; Myocardial Infarction; Substance P | 2014 |
Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cardiotonic Agents; Coronary Circulation; Cyclic AMP-Dependent Protein Kinase Catalytic Subunits; Disease Models, Animal; Fluorescent Antibody Technique; Isoindoles; Isoquinolines; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neurokinin-1 Receptor Antagonists; Oligopeptides; Peptide Fragments; Protein Kinase C-epsilon; Protein Kinase Inhibitors; Radioimmunoassay; Receptor, PAR-2; Receptors, Calcitonin Gene-Related Peptide; Receptors, Neurokinin-1; Recovery of Function; Substance P; Sulfonamides; TRPV Cation Channels; Ventricular Function, Left; Ventricular Pressure | 2009 |
Up-regulation of substance P in the lungs during acute myocardial ischemia and infarction in rats.
Topics: Animals; Ganglia, Spinal; Immunohistochemistry; Lung; Male; Myocardial Infarction; Myocardial Ischemia; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substance P; Up-Regulation | 2010 |
Degeneration of capsaicin sensitive sensory nerves enhances myocardial injury in acute myocardial infarction in rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Caspase 3; Myocardial Infarction; Myocardium; Nerve Degeneration; Neurokinin-1 Receptor Antagonists; Neurons, Afferent; Rats; Substance P | 2012 |
Myocardial infarction stimulates galanin expression in cardiac sympathetic neurons.
Topics: Animals; Coronary Vessels; Galanin; Gene Expression; Heart; Ligation; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Neurons; Neuropeptide Y; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P; Sympathetic Nervous System; Vasoactive Intestinal Peptide | 2005 |
TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice.
Topics: Animals; Indoles; Ischemic Preconditioning, Myocardial; Isoindoles; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neurokinin-1 Receptor Antagonists; Receptors, Calcitonin Gene-Related Peptide; Receptors, Neurokinin-1; Substance P; TRPV Cation Channels; Ventricular Dysfunction, Left | 2007 |
Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation.
Topics: Animals; Bleeding Time; Blood Flow Velocity; Blood Platelets; Hemostasis; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Myocardial Infarction; Platelet Activation; Receptors, Neurokinin-1; Stroke; Substance P; Thromboembolism | 2008 |
Human heart mast cells: a definitive case of mast cell heterogeneity.
Topics: Antibodies, Anti-Idiotypic; Complement Activation; Dose-Response Relationship, Immunologic; Genetic Heterogeneity; Histamine Release; Humans; Immunoglobulin E; Leukotriene C4; Lung; Mast Cells; Myocardial Infarction; Myocardium; Protamines; Skin; Substance P | 1995 |
Effect of chronic myocardial infarction on in vivo reactivity of skeletal muscle arterioles.
Topics: Acetylcholine; Animals; Arginine; Arterioles; Calcitonin Gene-Related Peptide; Chronic Disease; Hemodynamics; Male; Muscle, Skeletal; Myocardial Infarction; Nitroprusside; Rats; Rats, Sprague-Dawley; Substance P; Vasomotor System | 1997 |
Dilatory responses to acetylcholine, calcitonin gene-related peptide and substance P in the congestive heart failure rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Calcitonin Gene-Related Peptide; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Failure; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Ischemia; Potassium; Rats; Rats, Sprague-Dawley; Substance P; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1999 |
Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.
Topics: Adult; Arteries; Arteriosclerosis; Blood Flow Velocity; Case-Control Studies; Endothelium, Vascular; Female; Fibrinolysis; Forearm; Humans; Male; Middle Aged; Models, Biological; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Plethysmography; Risk Factors; Smoking; Substance P; Thrombosis; Tissue Plasminogen Activator | 1999 |